Event Abstract

Study of the impact of Tau phosphorylation on its internalization and processing in cultured neuronal cells

  • 1 Umons, Faculty of Medicine and Pharmacy, Belgium

Several studies have already revealed the propagation of Tau protein aggregates in different brain regions according to a stereotypical scheme that might explained the successive onset of symptoms in Alzheimer’s disease. In comparison, the implication of soluble Tau proteins in this transmission is poorly reported in the literature even though it seems that they constitute the most toxic species. In this study, we hypothesized that the phosphorylation of the protein, which is implied in its intracellular aggregation, could also play a role in this transmission. We applied two recombinant monomeric Tau proteins presenting a distinct phosphorylation state in the extracellular space of neuroblastoma cells (N2A) and of primary embryonic cortical cells. Proteins were detected by immunocytochemistry through a his-Tag included at their C-terminal extremity. We observed that the phosphorylation increased protein internalization by up to 10 times within both cell types. However, cellular distribution and processing of the phosphorylated protein were different in N2A cells and in cortical neurons. In N2A cells, proteins were found mainly around the nucleus up to 3 days after the period of incubation. Conversely, in cortical cells, proteins were much more distributed in soma and neurites and disappeared 24h after the end of the incubation period. This could be explained either by a digestion or an exocytosis of the protein. These two hypotheses will be tested by further experiments and the formation of intra-cytoplasmic aggregates will be studied in the presence of phosphorylated or non-phosphorylated proteins. These results could help to better understand the role of extracellular tau in the propagation of the disease and in the associated synaptic transmission deficits.

Acknowledgements

We would like to thank Progenosis who generously supplied us with non-phosphorylated and phosphorylated Tau proteins

References

CLAVAGUERA F., BOLMONT T., CROWTHER R. A., ABRAMOWSKI D., FRANK S., PROBST A., FRASER G., STALDER A. K., BEIBEL M., STAUFENBIEL M., JUCKER M., GOEDERT M., TOLNAY M. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol., 11(7) : 909-901.

DAVID D. C., LAYFIELD R., SERPELL L., NARAIN Y., GOEDERT M., SPILLANTINI M. G. (2002). Proteasomal degradation of tau protein. Journal of Neurochemistry, 83: 176-185.

DUJARDIN S., LECOLLE K., CAILLIEREZ R., BEGARD S., ZOMMER N., LACHAUD C., CARRIER S., DUFOUR N., AUREGAN G., WINDERINCKX J., HANTRAYE P., DEGLON N., COLIN M., BUEE L. (2014). Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathologica Communications, 2:14.

FLACH K., HILBRICH I., SCHIFFMANN A., GARTNER U., KRUGER M., LEONHARDT M., WASCHIPKY H., WICK L., ARENDT T., HOLZER M. (2012). Tau Oligomers Impair Artificial Membrane Integrity and Cellular Vability. Journal of Biological Chemistry, 287(52):43223-43233.

FROST B., JACKS R. L., DIAMOND M. I. (2009). Propagation of Tau Misfolding from the Outside to the Inside of a Cell. Journal of Biological Chemistry, 284:12845-12852.

GIANNACOPOULOS P. (2003). Tangles and neuron numbers but not amyloid load predict cognitive status in Alzheimer's disease. Annals of General Hospital Psychiatry, 2: S18.

GUO J. L., LEE V. M. Y. (2013). Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau. FEBS Letters, 587: 717-723.

LASAGNA-REEVES C. A., CASTILLO-CARRANZA D. L., SENGUPTA U., CLOS A. L., JACKSON J. R., KAYED R. (2011). Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Molecular Neurodegeneration, 6:39.

LIU L., DROUET V., WU J. W., WITTER M. P., SMALL S. A., CLELLAND C., DUFF K. (2012). Trans-synaptic Spread of Tau Pathology In Vivo. Plos One, 7(2): e31302.

MEDINA M., AVILA J. (2014). New perspectives on the role of tau in Alzheimer’s disease. Implications for therapy. Biochemical Pharmacology, 88 : 540-547.

MICHEL C. H., KUMAR S., PINOTSI D., TUNNACLIFFE A., ST.GEORGE-HYSLOP P., MANDELKOW E., MANDELKOW E-M., KAMINSKI C. F., KAMINSKI SCHIERLE G. S. (2013). Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology. Journal of Biological Chemistry, 289:956-967.

SANTA-MARIA I., VARGHESE M., KSIZAK-REDING H., DZHUN A., WANG J., PASINETTI M. (2012). Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. The Journal of Biological Chemistry, 287: 20522-20533.

SAMAN S., KIM W., RAYA M., VISNICK Y., MIRO S., SAMAN S., JACKSON B., MCKEE AC., ALVAREZ VE., LEE NC., HALL GF. (2011). Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. The Journal of Biological Chemistry, 287(6): 3842-3849.

TAI H-C., WANG B. Y., SERRANO-POZO A., FROSCH M. P., SPIRES-JONES T. L., HYMAN B. T. (2014) Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease. Acta Neuropathologica communications, 2: 146.

WANG Y., MARTINEZ-VICENTE M., KRUGER U., KAUSHIK S., WONG E., MANDELKOW E-M., CUERVO A-M., MANDELKOW E. (2009). Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Human Molecular Genetics, 18(2): 4153-4170.

Keywords: tau protein, Extracellular Space, Phosphorylation, neuronal cell culture, propagation

Conference: 11th National Congress of the Belgian Society for Neuroscience, Mons, Belgium, 22 May - 22 May, 2015.

Presentation Type: Poster presentation

Topic: Neuroscience

Citation: Wauters M, Paci P and Ris L (2015). Study of the impact of Tau phosphorylation on its internalization and processing in cultured neuronal cells. Front. Neurosci. Conference Abstract: 11th National Congress of the Belgian Society for Neuroscience. doi: 10.3389/conf.fnins.2015.89.00001

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 05 May 2015; Published Online: 05 May 2015.

* Correspondence: Miss. Mathilde Wauters, Umons, Faculty of Medicine and Pharmacy, Mons, Hainaut, B-7000, Belgium, mathilde.wauters@student.umons.ac.be